IDenta Corp. (IDTA)

Market Cap	1.55M -14.7%
Revenue (ttm)	1.86M +57.3%
Net Income	141.05K
EPS	0.03
Shares Out	4.37M
PE Ratio	11.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,502
Open	0.2700
Previous Close	0.3560
Day's Range	0.2700 - 0.3560
52-Week Range	0.1511 - 0.3560
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 18, 2026

About IDenta

IDenta Corp. operates as a detection and forensic science company. The company offers drug, and explosives testing kits; aero chamber sniffer; forensic; and urine, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Australia, Canada, and inte...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2002
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDTA

Financial Performance

In 2025, IDenta's revenue was $1.34 million, a decrease of -7.86% compared to the previous year's $1.46 million. Earnings were $99,044, a decrease of -61.66%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 10, 2026

Data Sources Report a data error